- Home
- OPTT vs CYCN Comparison
OPTT vs CYCN Comparison
Compare OPTT & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTT
- CYCN
- Stock Information
- Founded
- OPTT 1984
- CYCN 2018
- Country
- OPTT United States
- CYCN United States
- Employees
- OPTT N/A
- CYCN N/A
- Industry
- OPTT Electric Utilities: Central
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- OPTT Utilities
- CYCN Health Care
- Exchange
- OPTT Nasdaq
- CYCN Nasdaq
- Market Cap
- OPTT 89.7M
- CYCN 6.5M
- IPO Year
- OPTT 2007
- CYCN N/A
- Fundamental
- Price
- OPTT $0.51
- CYCN $3.09
- Analyst Decision
- OPTT
- CYCN
- Analyst Count
- OPTT 0
- CYCN 0
- Target Price
- OPTT N/A
- CYCN N/A
- AVG Volume (30 Days)
- OPTT 3.6M
- CYCN 25.7K
- Earning Date
- OPTT 07-24-2025
- CYCN 08-06-2025
- Dividend Yield
- OPTT N/A
- CYCN N/A
- EPS Growth
- OPTT N/A
- CYCN N/A
- EPS
- OPTT N/A
- CYCN N/A
- Revenue
- OPTT $6,117,000.00
- CYCN $2,081,000.00
- Revenue This Year
- OPTT N/A
- CYCN N/A
- Revenue Next Year
- OPTT N/A
- CYCN N/A
- P/E Ratio
- OPTT N/A
- CYCN N/A
- Revenue Growth
- OPTT 24.00
- CYCN N/A
- 52 Week Low
- OPTT $0.14
- CYCN $1.27
- 52 Week High
- OPTT $1.75
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- OPTT 51.14
- CYCN 50.71
- Support Level
- OPTT $0.45
- CYCN $3.02
- Resistance Level
- OPTT $0.53
- CYCN $3.50
- Average True Range (ATR)
- OPTT 0.04
- CYCN 0.27
- MACD
- OPTT -0.00
- CYCN 0.02
- Stochastic Oscillator
- OPTT 48.08
- CYCN 48.10
About OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.